Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 251

Results For "market"

3695 News Found

Avet Pharmaceuticals appoints George Svokos as President &CEO
People | July 18, 2022

Avet Pharmaceuticals appoints George Svokos as President &CEO

George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies


Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
News | July 16, 2022

Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA

ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.


UPS Healthcare revolutionizes prioritized shipping with UPS Premier
Supply Chain | July 16, 2022

UPS Healthcare revolutionizes prioritized shipping with UPS Premier

Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products


India Health Link join hands with Canopi
Supply Chain | July 16, 2022

India Health Link join hands with Canopi

To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India


Enveda appoints Vanitha Sekar as Chief Business Officer
People | July 16, 2022

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences


Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
News | July 15, 2022

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality

Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals


Syngene signs 10-year biologics manufacturing agreement with Zoetis
News | July 15, 2022

Syngene signs 10-year biologics manufacturing agreement with Zoetis

Syngene's collaboration with Zoetis started in 2011


Cipla Health signs agreement to acquire Endura Mass
News | July 15, 2022

Cipla Health signs agreement to acquire Endura Mass

This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.


CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
News | July 15, 2022

CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine

Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.


USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list
Drug Approval | July 14, 2022

USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list

Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.